Grant of Options

RNS Number : 1402P

Deltex Medical Group PLC

28 September 2011

 



Deltex Medical Group plc

Grant of options

28 September 2011 - Deltex Medical Group plc (the "Company"), the global leader in oesophageal Doppler monitoring ("ODM"), announces that yesterday the Board approved the issue of share options to Ewan Phillips, Chief Executive and Paul Mitchell, Finance Director.

Employee Share Option Scheme

The Board has approved the issue of share options to Ewan Phillips, Chief Executive, and Paul Mitchell, Finance Director, under the Company's 2011 Executive Share Option Scheme as follows:

Name	Number	Exercise Price £	Exercise period	Total Number of options held*
Ewan Phillips	1,000,000	0.1725	2004 - 2021	3,480,000
Paul Mitchell	300,000	0.1725	2005 - 2021	915,000

*The total number of options held includes those awarded under the Company's 2001 Executive Share Option Scheme

These options are subject to certain performance conditions being achieved.

EMI scheme - bonus award

The Company's 2003 Enterprise Management Incentive Scheme ('EMI Scheme') allows directors and employees who have earned performance related bonus payments under the terms of their employment to sacrifice their entitlement to cash payment in return for share options nominal value. The EMI Scheme also allows directors and employees to make similar sacrifices in respect of accrued salary.

Ewan Phillips has elected to sacrifice the whole (£75,000) of the performance bonus awarded by the Company's Remuneration Committee in respect of the year ended 31 December 2010 and his entitlement to £7,500 of salary in respect of the period from 1 April 2011 to 30 September 2011. Paul Mitchell has elected to sacrifice the whole (£21,650) of the performance bonus awarded by the Company's Remuneration Committee in respect of the year ended 31 December 2010. As a result awards of options under the EMI Scheme are as follows:

Name	Number	Exercise Price £	Exercise period	Total Number of EMI options held (inc. salary sacrifice below)
Ewan Phillips	507,692	0.01	2004 - 2021	3,430,068
Paul Mitchell	133,231	0.01	2010 - 2021	186,768

Additional interests

Mr Phillips also has a beneficial interest in 1,159,773 ordinary shares in the Company representing 0.84 per cent of the issued ordinary share capital of the Company.

Mr Mitchell also has a beneficial interest in 154,219 ordinary shares in the Company representing 0.11 per cent of the issued ordinary share capital of the Company.

All shares and options relate to ordinary 1p shares.

For further information, please contact:-

Deltex Medical Group plc                                                                    01243 774 837
Nigel Keen, Chairman                                        
Ewan Phillips, Chief Executive                           
Paul Mitchell, Finance Director               

Nominated Adviser and Broker                                                            020 7614 5917

Arden Partners plc 

Christopher Hardie

Jamie Cameron

 

END

 

 

RDSLLFLRAEITFIL